Office of Minority Health and Health Equity Strategic Priorities; Reopening of the Comment Period

Resumo

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice, published in the Federal Register of January 3, 2020. In the notice, FDA opened a public docket to solicit input and comments from interested stakeholders, including racial and ethnic minority, underrepresented, and underserved populations on the Office of Minority Health and Health Equity Strategic Priorities (OMHHE). FDA is reopening the comment period to update comments and to receive any new information.